REGULUS THERAPEUTICS INC - COM (RGLS)

CUSIP: 75915K101

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
14,719,568
Share change
+30,437
Total reported value
$108,778,057
Price per share
$7.39
Number of holders
48
Value change
+$224,908
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 75915K101?
CUSIP 75915K101 identifies RGLS - REGULUS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q4 2013

As of 31 Dec 2013, REGULUS THERAPEUTICS INC - COM (RGLS) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,719,568 shares. The largest 10 holders included FMR LLC, HealthCor Management, L.P., MARXE AUSTIN W & GREENHOUSE DAVID M, GOLDMAN SACHS GROUP INC, WELLINGTON MANAGEMENT CO LLP, BlackRock Fund Advisors, JENNISON ASSOCIATES LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Institutional Trust Company, N.A., and VANGUARD GROUP INC. This page lists 48 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.